Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Response to Letter Regarding Article, “Galectin-3 and Cardiac Function in Survivors of Acute Myocardial Infarction”.

Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, McMurray JJ.

Circ Heart Fail. 2013 Jul;6(4):e58. No abstract available.

2.

Letter by Januzzi regarding article, "galectin-3 and cardiac function in survivors of acute myocardial infarction".

Januzzi JL.

Circ Heart Fail. 2013 Jul;6(4):e57. doi: 10.1161/CIRCHEARTFAILURE.113.000375. No abstract available.

3.

Galectin-3 and cardiac function in survivors of acute myocardial infarction.

Weir RA, Petrie CJ, Murphy CA, Clements S, Steedman T, Miller AM, McInnes IB, Squire IB, Ng LL, Dargie HJ, McMurray JJ.

Circ Heart Fail. 2013 May;6(3):492-8. doi: 10.1161/CIRCHEARTFAILURE.112.000146. Epub 2013 Mar 15.

4.

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice.

Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, Struthers AD, Voors AA, Ruilope LM, Bakris GL, O'Connor CM, Gheorghiade M, Mentz RJ, Cohen-Solal A, Maggioni AP, Beygui F, Filippatos GS, Massy ZA, Pathak A, Piña IL, Sabbah HN, Sica DA, Tavazzi L, Pitt B.

Eur Heart J. 2012 Nov;33(22):2782-95. doi: 10.1093/eurheartj/ehs257. Epub 2012 Aug 31. Review.

5.

Biomarkers, mineralocorticoid receptor antagonism, and cardiorenal remodeling.

Fiuzat M, Burnett JC Jr.

JACC Heart Fail. 2015 Jan;3(1):68-9. doi: 10.1016/j.jchf.2014.10.003. Epub 2014 Nov 11. No abstract available.

PMID:
25458173
6.

Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.

Chabot A, Jiang BH, Shi Y, Tardif JC, Dupuis J.

BMC Cardiovasc Disord. 2011 Dec 2;11:72. doi: 10.1186/1471-2261-11-72.

7.
8.

Impact of mineralocorticoid receptor antagonists on changes in cardiac structure and function of left ventricular dysfunction: a meta-analysis of randomized controlled trials.

Li X, Qi Y, Li Y, Zhang S, Guo S, Chu S, Gao P, Zhu D, Wu Z, Lu L, Shen W, Jia N, Niu W.

Circ Heart Fail. 2013 Mar;6(2):156-65. doi: 10.1161/CIRCHEARTFAILURE.112.000074. Epub 2013 Feb 11.

9.

Circulating stromelysin-1 (MMP-3): a novel predictor of LV dysfunction, remodelling and all-cause mortality after acute myocardial infarction.

Kelly D, Khan S, Cockerill G, Ng LL, Thompson M, Samani NJ, Squire IB.

Eur J Heart Fail. 2008 Feb;10(2):133-9. doi: 10.1016/j.ejheart.2007.12.009. Epub 2008 Jan 30.

10.

Relation of cardiac troponin I and microvascular obstruction following ST-elevation myocardial infarction.

Hallén J, Jensen JK, Buser P, Jaffe AS, Atar D.

Acute Card Care. 2011 Mar;13(1):48-51. doi: 10.3109/17482941.2010.538698. Epub 2011 Jan 18.

PMID:
21244230
11.

Attenuation of left ventricular adverse remodeling with epicardial patching after myocardial infarction.

Liao SY, Siu CW, Liu Y, Zhang Y, Chan WS, Wu EX, Wu Y, Nicholls JM, Li RA, Benser ME, Rosenberg SP, Park E, Lau CP, Tse HF.

J Card Fail. 2010 Jul;16(7):590-8. doi: 10.1016/j.cardfail.2010.02.007. Epub 2010 Apr 3.

PMID:
20610235
12.

Galectin-3 expression in cardiac remodeling after myocardial infarction.

Sanchez-Mas J, Lax A, Asensio-Lopez MC, Fernandez-Del Palacio MJ, Caballero L, Garrido IP, Pastor F, Januzzi JL, Pascual-Figal DA.

Int J Cardiol. 2014;172(1):e98-e101. doi: 10.1016/j.ijcard.2013.12.129. Epub 2014 Jan 4. No abstract available.

PMID:
24433619
13.

Galectin-3: relation to infarct scar and left ventricular function after myocardial infarction.

Mayr A, Klug G, Mair J, Streil K, Harrasser B, Feistritzer HJ, Jaschke W, Schocke M, Pachinger O, Metzler B.

Int J Cardiol. 2013 Mar 10;163(3):335-7. doi: 10.1016/j.ijcard.2012.06.087. Epub 2012 Jul 13. No abstract available.

PMID:
22795719
14.

C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.

Kelly D, Squire IB, Khan SQ, Quinn P, Struck J, Morgenthaler NG, Davies JE, Ng LL.

J Card Fail. 2008 Nov;14(9):739-45. doi: 10.1016/j.cardfail.2008.07.231. Epub 2008 Aug 30.

PMID:
18995178
15.
16.

Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.

Hayashi M, Tsutamoto T, Wada A, Tsutsui T, Ishii C, Ohno K, Fujii M, Taniguchi A, Hamatani T, Nozato Y, Kataoka K, Morigami N, Ohnishi M, Kinoshita M, Horie M.

Circulation. 2003 May 27;107(20):2559-65. Epub 2003 May 5.

17.

[Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: randomized and double-blind study].

Rodríguez JA, Godoy I, Castro P, Quintana JC, Chávez E, Yovanovich J, Corbalán R, Chávez A.

Rev Med Chil. 1997 Jun;125(6):643-52. Spanish.

PMID:
9515282
18.

Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.

Noda K, Kobara M, Hamada J, Yoshifuji Y, Shiraishi T, Tanaka T, Wang J, Toba H, Nakata T.

J Cardiovasc Pharmacol. 2012 Aug;60(2):140-9. doi: 10.1097/FJC.0b013e318258f8ce.

PMID:
22549451
19.

[Effect of spironolactone on mortality in patients with severe left ventricular dysfunction after acute myocardial infarction].

Ruta J, Ptaszyński P, Maciejewski M, Chizyński K, Goch JH.

Przegl Lek. 2006;63(12):1249-51. Polish.

PMID:
17642132
20.

Relation of terminal QRS distortion to left ventricular functional recovery and remodeling in acute myocardial infarction treated with primary angioplasty.

Bigi R, Mafrici A, Colombo P, Gregori D, Corrada E, Alberti A, De Biase A, Orrego PS, Fiorentini C, Klugmann S.

Am J Cardiol. 2005 Nov 1;96(9):1233-6. Epub 2005 Sep 2.

PMID:
16253588
Items per page

Supplemental Content

Write to the Help Desk